Spectranetics, Medtronic settle intellectual property suit
COLORADO SPRINGS, Colo.—Spectranetics Corp. said Monday it has settled its intellectual property dispute with Medtronic, with Medtronic licensing the patent at issue.
Terms of the settlement agreement were not disclosed.
Spectranetics' disposable catheters use high-energy ultraviolet light to vaporize artery blockages in the legs and heart, as well as scar tissue surrounding pacing and defibrillation leads.![]()
© Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


